Bruno Galli

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease

Ulf Neumann, Mike Ufer, Laura H. Jacobson et al. · EMBO Molecular Medicine · 2018 · 172 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state

Fanny De Jaeghere, Éric Allémann, F. Kubel et al. · Journal of Controlled Release · 2000 · 92 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Transformation of acidic poorly water soluble drugs into ionic liquids

Anja Balk, Johannes Wiest, Toni Widmer et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2015 · 89 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice

Jean-Christophe Leroux, Robert Cozens, Johannes Roesel et al. · Journal of Pharmaceutical Sciences · 1995 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

High protein yogurt with addition of Lactobacillus helveticus: Peptide profile and angiotensin-converting enzyme ACE-inhibitory activity

Flávia Giacometti Cavalheiro, Débora Parra Baptista, Bruno Galli et al. · Food Chemistry · 2020 · 73 citations · Full text

Agriculture, Dairy Science, Food Science +17